Jager MJ - Search Results

1

The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group.

Jouhi S, Jager MJ, de Geus SJR, Desjardins L, Eide NA, Grange JD, Kiilgaard JF, Seregard S, Midena E, Parrozzani R, Caujolle JP, Rospond-Kubiak I, Kivelä TT. Jouhi S, et al. Among authors: jager mj. Am J Ophthalmol. 2019 Jun;202:100-108. doi: 10.1016/j.ajo.2019.01.031. Epub 2019 Feb 15. Am J Ophthalmol. 2019. PMID: 30772347 Free article.

2

Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.

All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O. All-Ericsson C, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):1-8. Invest Ophthalmol Vis Sci. 2002. PMID: 11773005

3

Prognostic value of S-100-beta serum concentration in patients with uveal melanoma.

Missotten GS, Tang NE, Korse CM, Hurks HM, de Wolff-Rouendaal D, Keunen JE, Jager MJ, Bonfrer JM. Missotten GS, et al. Among authors: jager mj. Arch Ophthalmol. 2003 Aug;121(8):1117-9. doi: 10.1001/archopht.121.8.1117. Arch Ophthalmol. 2003. PMID: 12912688

4

Prognostic value of the disodium phosphate 32P uptake test in uveal melanoma: a long-term study.

Overkleeft EN, Zuidervaart W, Hurks HM, Eilers PH, de Wolff-Rouendaal D, Jager MJ. Overkleeft EN, et al. Among authors: jager mj. Arch Ophthalmol. 2003 Oct;121(10):1398-403. doi: 10.1001/archopht.121.10.1398. Arch Ophthalmol. 2003. PMID: 14557175

5

Epigenetic inactivation of RASSF1a in uveal melanoma.

Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA. Maat W, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2007 Feb;48(2):486-90. doi: 10.1167/iovs.06-0781. Invest Ophthalmol Vis Sci. 2007. PMID: 17251440

6

The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology.

Finger PT; 7th Edition, AJCC-UICC Ophthalmic Oncology Task Force. Finger PT, et al. Arch Pathol Lab Med. 2009 Aug;133(8):1197-8. doi: 10.5858/133.8.1197. Arch Pathol Lab Med. 2009. PMID: 19653708 Free article. No abstract available.

7

Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.

Ly LV, Odish OF, Wolff-Rouendaal Dd, Missotten GS, Luyten GP, Jager MJ. Ly LV, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2010 Feb;51(2):658-65. doi: 10.1167/iovs.09-3824. Epub 2009 Sep 24. Invest Ophthalmol Vis Sci. 2010. PMID: 19797220

8

Detection of M2-macrophages in uveal melanoma and relation with survival.

Bronkhorst IH, Ly LV, Jordanova ES, Vrolijk J, Versluis M, Luyten GP, Jager MJ. Bronkhorst IH, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2011 Feb 3;52(2):643-50. doi: 10.1167/iovs.10-5979. Invest Ophthalmol Vis Sci. 2011. PMID: 20811059

9

Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.

Bronkhorst IH, Maat W, Jordanova ES, Kroes WG, Schalij-Delfos NE, Luyten GP, Jager MJ. Bronkhorst IH, et al. Among authors: jager mj. Arch Pathol Lab Med. 2011 Aug;135(8):1042-7. doi: 10.5858/2010-0477-OAR1. Arch Pathol Lab Med. 2011. PMID: 21809997 Free article.

10

Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.

Khan S, Finger PT, Yu GP, Razzaq L, Jager MJ, de Keizer RJ, Sandkull P, Seregard S, Gologorsky D, Schefler AC, Murray TG, Kivelä T, Giuliari GP, McGowan H, Simpson ER, Corriveau C, Coupland SE, Damato BE. Khan S, et al. Among authors: jager mj. Arch Ophthalmol. 2012 Jan;130(1):57-64. doi: 10.1001/archophthalmol.2011.286. Epub 2011 Sep 12. Arch Ophthalmol. 2012. PMID: 21911649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters